학술논문
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors
Document Type
Article
Author
Source
In: Investigational New Drugs . (Investigational New Drugs, June 2024, 42(3):241-251)
Subject
Language
English
ISSN
15730646
01676997
01676997